On July 28, the three-day 74th AACC annual meeting of American clinical chemistry and Clinical Laboratory Equipment Expo officially ended. As one of the most important international academic conferences in the field of clinical testing in the world, AACC annual conference has important international influence. Each annual conference attracts more than 20000 professionals and medical care leaders from more than 100 countries in the world.
Exhibition review
This time, AACC and Uni-medica carried lamp portable constant temperature amplification analyzer, POCT immunofluorescence analyzer, novel coronavirus detection whole process solution, TNGS pathogen targeted sequencing and other products to participate in the exhibition.
As the preferred supplier of global molecular diagnostic testing reagents and instruments, Uni-medica has exported its products to many countries around the world and accumulated a good reputation in the global market. During the exhibition, industry experts, customers and media from all over the world came to the Uni-medica booth to visit and exchange views, and gave high recognition and evaluation to the products and technologies of Uni-medica.
Located in Nanshan District, Shenzhen City, Uni-medica(hereinafter referred to as "Uni-medica") is a national high-tech enterprise. It is committed to the development of in vitro diagnostic reagents and instrument integration solutions. It has carried out a series of scientific research cooperation with many scientific research institutions such as Hong Kong University of Science and technology, Shenzhen University and Chinese Academy of Sciences, and has undertaken many national and provincial scientific and technological research projects, It was invested by Xiantong capital and Shenzhen Science and technology financial service center, and was selected as one of the top 100 innovative enterprises in China.
Uni-medica focuses on the R & D and industrialization of innovative products in the fields related to infectious diseases and reproductive health. It has a number of technical platforms such as fluorescence quantitative PCR platform, high-throughput sequencing platform, flow cytometer platform and immunofluorescence microscopy imaging platform, as well as a mature and complete medical device production registration system. It provides a complete solution for accurate diagnosis in the fields of infectious diseases and reproductive health based on multi omics detection technology.
.png)
.jpg)
